Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2015 1
2018 1
2021 3
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Stepwise Methane-to-Methanol Conversion on CuO/SBA-15.
Le HV, Parishan S, Sagaltchik A, Ahi H, Trunschke A, Schomäcker R, Thomas A. Le HV, et al. Chemistry. 2018 Aug 27;24(48):12592-12599. doi: 10.1002/chem.201801135. Epub 2018 Jul 23. Chemistry. 2018. PMID: 29802668
An 89Zr-Labeled PSMA Tracer for PET/CT Imaging of Prostate Cancer Patients.
Dietlein F, Kobe C, Vázquez SM, Fischer T, Endepols H, Hohberg M, Reifegerst M, Neumaier B, Schomäcker K, Drzezga AE, Dietlein M. Dietlein F, et al. J Nucl Med. 2022 Apr;63(4):573-583. doi: 10.2967/jnumed.121.262290. Epub 2021 Jul 29. J Nucl Med. 2022. PMID: 34326129 Free article.
Furthermore, comparison of the 15 (89)Zr-PSMA-DFO-positive lesions with their correlates on the original PET scan revealed that established tracers exhibited mild accumulation in 7 of 15 lesions; however, contrast-to-noise ratios were too low for robust detection of these lesions …
Furthermore, comparison of the 15 (89)Zr-PSMA-DFO-positive lesions with their correlates on the original PET scan revealed that established …
Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer.
Vázquez SM, Endepols H, Fischer T, Tawadros SG, Hohberg M, Zimmermanns B, Dietlein F, Neumaier B, Drzezga A, Dietlein M, Schomäcker K. Vázquez SM, et al. Mol Imaging Biol. 2022 Feb;24(1):115-125. doi: 10.1007/s11307-021-01632-x. Epub 2021 Aug 9. Mol Imaging Biol. 2022. PMID: 34370181 Free PMC article.
A late [(89)Zr]Zr-PSMA-DFO PET scan on a patient with biochemical recurrence (BCR) had demonstrated intensive tracer accumulation in the right (SUV(max) 13.25, 48 h p.i.) and in the left prostate lobe (SUV max 9.47), a repeat biopsy revealed cancer cells on both sid …
A late [(89)Zr]Zr-PSMA-DFO PET scan on a patient with biochemical recurrence (BCR) had demonstrated intensive tracer accumulation in the rig …
Protonated Imine-Linked Covalent Organic Frameworks for Photocatalytic Hydrogen Evolution.
Yang J, Acharjya A, Ye MY, Rabeah J, Li S, Kochovski Z, Youk S, Roeser J, Grüneberg J, Penschke C, Schwarze M, Wang T, Lu Y, van de Krol R, Oschatz M, Schomäcker R, Saalfrank P, Thomas A. Yang J, et al. Angew Chem Int Ed Engl. 2021 Sep 1;60(36):19797-19803. doi: 10.1002/anie.202104870. Epub 2021 Jul 26. Angew Chem Int Ed Engl. 2021. PMID: 34043858 Free PMC article.
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.
Dietlein M, Kobe C, Kuhnert G, Stockter S, Fischer T, Schomäcker K, Schmidt M, Dietlein F, Zlatopolskiy BD, Krapf P, Richarz R, Neubauer S, Drzezga A, Neumaier B. Dietlein M, et al. Mol Imaging Biol. 2015 Aug;17(4):575-84. doi: 10.1007/s11307-015-0866-0. Mol Imaging Biol. 2015. PMID: 26013479 Free PMC article.
A systematic comparison was carried out between results obtained with both tracers with regard to the number of detected PSMA-positive lesions, the standardized uptake value (SUV)max and the lesion to background ratios. RESULTS: All suspicious lesions identified by [(68)Ga …
A systematic comparison was carried out between results obtained with both tracers with regard to the number of detected PSMA-positive lesio …